ATE174799T1 - Antiidiotypischer antikörper, der eine immunantwort gegen ein glykosphingolipid induziert und seine verwendung - Google Patents

Antiidiotypischer antikörper, der eine immunantwort gegen ein glykosphingolipid induziert und seine verwendung

Info

Publication number
ATE174799T1
ATE174799T1 AT90909554T AT90909554T ATE174799T1 AT E174799 T1 ATE174799 T1 AT E174799T1 AT 90909554 T AT90909554 T AT 90909554T AT 90909554 T AT90909554 T AT 90909554T AT E174799 T1 ATE174799 T1 AT E174799T1
Authority
AT
Austria
Prior art keywords
immune response
response against
induces
glycosphingolipide
antiidiotypic antibody
Prior art date
Application number
AT90909554T
Other languages
English (en)
Inventor
Paul B Chapman
Alan N Houghton
Original Assignee
Sloan Kettering Inst Cancer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sloan Kettering Inst Cancer filed Critical Sloan Kettering Inst Cancer
Application granted granted Critical
Publication of ATE174799T1 publication Critical patent/ATE174799T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4208—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
    • C07K16/4241—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig
    • C07K16/4258—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig against anti-receptor Ig
    • C07K16/4266—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig against anti-receptor Ig against anti-tumor receptor Ig
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
    • A61K47/6873—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting an immunoglobulin; the antibody being an anti-idiotypic antibody
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT90909554T 1989-05-25 1990-05-25 Antiidiotypischer antikörper, der eine immunantwort gegen ein glykosphingolipid induziert und seine verwendung ATE174799T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US35703789A 1989-05-25 1989-05-25

Publications (1)

Publication Number Publication Date
ATE174799T1 true ATE174799T1 (de) 1999-01-15

Family

ID=23404043

Family Applications (2)

Application Number Title Priority Date Filing Date
AT90909554T ATE174799T1 (de) 1989-05-25 1990-05-25 Antiidiotypischer antikörper, der eine immunantwort gegen ein glykosphingolipid induziert und seine verwendung
AT98108374T ATE243713T1 (de) 1989-05-25 1990-05-25 Antiidiotypischer antikörper, der ein immunantwort gegen ein glykosphingolipid induziert und seine verwendung

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT98108374T ATE243713T1 (de) 1989-05-25 1990-05-25 Antiidiotypischer antikörper, der ein immunantwort gegen ein glykosphingolipid induziert und seine verwendung

Country Status (9)

Country Link
US (1) US5529922A (de)
EP (3) EP1334984A1 (de)
JP (1) JP3392860B2 (de)
AT (2) ATE174799T1 (de)
CA (1) CA2057010C (de)
DE (3) DE473721T1 (de)
DK (2) DK0473721T3 (de)
ES (2) ES2207768T3 (de)
WO (1) WO1990014104A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6432402B1 (en) 1989-05-25 2002-08-13 Sloan-Kettering Institute For Cancer Research Anti-idiotypic antibody which induces an immune response against a glycosphingolipid and use thereof
US6805862B1 (en) 1989-05-25 2004-10-19 Sloan-Kattering Institute For Cancer Research Anti-idiotypic antibody which induces an immune response against a glycosphingolipid and use thereof
US5268454A (en) * 1991-02-08 1993-12-07 La Jolla Pharmaceutical Company Composition for inducing humoral anergy to an immunogen comprising a t cell epitope-deficient analog of the immunogen conjugated to a nonimmunogenic carrier
US20030035797A1 (en) * 1992-01-27 2003-02-20 Sloan-Kettering Institute For Cancer Research Anti-idiotypic antibody which induces an immune response against a glycosphingolipid and use thereof
US5874085A (en) * 1993-11-10 1999-02-23 Henry M. Jackson Foundation For The Advancement Of Military Medicine Vaccine for enhanced production of IgA antibodies
US6149921A (en) * 1993-12-29 2000-11-21 Centro De Inmunologia Molecular Vaccine compositions for eliciting an immune response against N-acetylated gangliosides and their use for cancer treatment
CU22420A1 (es) * 1993-12-29 1996-01-31 Centro Inmunologia Molecular Composicion vacunal para el desarrollo de una respuesta contra gangliosidos n glicolilados y su uso para el tratamiento del cancer
US5977316A (en) * 1995-01-17 1999-11-02 The Board Of Trustees Of The University Of Kentucky Monoclonal antibody 1A7 and related polypeptides
US5612030A (en) * 1995-01-17 1997-03-18 University Of Kentucky Research Foundation Anti-idiotype monoclonal antibody 1A7 and use for the treatment of melanoma and small cell carcinoma
US5935821A (en) 1995-01-17 1999-08-10 Board Of Trustees Of The University Of Kentucky Polynucleotides related to monoclonal antibody 1A7 and use for the treatment of melanoma and small cell carcinoma
US5792455A (en) * 1996-03-21 1998-08-11 Sloan-Kettering Institute For Cancer Research Anti-idiotypic antibody vaccines
US6355244B1 (en) 1997-11-17 2002-03-12 University Of Kentucky Research Foundation Methods and compositions for the treatment of psoriasis
DK1071700T3 (da) * 1998-04-20 2010-06-07 Glycart Biotechnology Ag Glykosylerings-modifikation af antistoffer til forbedring af antistofafhængig cellulær cytotoksicitet
US6989276B2 (en) 2001-05-10 2006-01-24 Battelle Energy Alliance, Llc Rapid classification of biological components
USRE46351E1 (en) 2001-05-10 2017-03-28 Battelle Energy Alliance, Llc Antibody profiling sensitivity through increased reporter antibody layering
NZ571596A (en) * 2001-08-03 2010-11-26 Glycart Biotechnology Ag Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity
US7927828B2 (en) * 2005-10-17 2011-04-19 Spidertech, a division of Stoecker & associates, LLC Immunoassay for venom detection including noninvasive sample collection
US20080286881A1 (en) * 2007-05-14 2008-11-20 Apel William A Compositions and methods for combining report antibodies
WO2011022103A2 (en) * 2009-08-18 2011-02-24 Medical College Of Georgia Research Institute, Inc. Ganglioside epitopes for treating guillain-barre syndrome
US9410965B2 (en) * 2009-09-17 2016-08-09 Battelle Energy Alliance, Llc Identification of discriminant proteins through antibody profiling, methods and apparatus for identifying an individual
US8969009B2 (en) * 2009-09-17 2015-03-03 Vicki S. Thompson Identification of discriminant proteins through antibody profiling, methods and apparatus for identifying an individual

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE32833E (en) * 1982-03-01 1989-01-17 President And Fellows Of Harvard College Screening vaccines and immunization process
EP0134868A1 (de) * 1983-08-26 1985-03-27 Anda Biologicals Glutaraldehyd-aktivierte einzellige Organismen als feste Träger für Sensibilisierungsmittel und Gebrauch von sensibilisierten einzelligen Organismen
US4918164A (en) * 1987-09-10 1990-04-17 Oncogen Tumor immunotherapy using anti-idiotypic antibodies
US5614610A (en) * 1984-12-21 1997-03-25 Oncogen Tumor immunotherapy using anti-idiotypic antibodies
EP0268640A4 (de) * 1986-05-07 1989-11-30 Sloan Kettering Inst Cancer Impfstoff zur stimulierung oder erhöhung von antikörpern gegen gm2.
IT1217314B (it) * 1987-02-20 1990-03-22 Sclavo Spa Nonapeptide sintetico ad attivita'adiuvante capace di potenziare in vivo la risposta anticorporale
US4849509A (en) * 1987-02-20 1989-07-18 The Wistar Institute Monoclonal antibodies against melanoma-associated antigens and hybrid cell lines producing these antibodies
AU1711888A (en) * 1987-04-24 1988-12-02 Biogen, Inc. Immunotherapeutic methods and compositions
US4900547A (en) * 1987-10-23 1990-02-13 University Of British Columbia Method to immunize mammals against tumors

Also Published As

Publication number Publication date
DE69032855T2 (de) 1999-08-12
JP3392860B2 (ja) 2003-03-31
DE69032855D1 (de) 1999-02-04
DK0473721T3 (da) 1999-08-23
JPH05500600A (ja) 1993-02-12
US5529922A (en) 1996-06-25
WO1990014104A1 (en) 1990-11-29
EP0884329B1 (de) 2003-06-25
DE69034087D1 (de) 2003-07-31
DE69034087T2 (de) 2004-05-06
EP0473721B1 (de) 1998-12-23
CA2057010A1 (en) 1990-11-26
ES2127186T3 (es) 1999-04-16
ATE243713T1 (de) 2003-07-15
DE473721T1 (de) 1993-04-29
EP0473721A1 (de) 1992-03-11
EP1334984A1 (de) 2003-08-13
DK0884329T3 (da) 2003-10-20
EP0473721A4 (de) 1994-03-23
EP0884329A1 (de) 1998-12-16
HK1014658A1 (en) 1999-09-30
CA2057010C (en) 2002-08-06
ES2207768T3 (es) 2004-06-01

Similar Documents

Publication Publication Date Title
ATE174799T1 (de) Antiidiotypischer antikörper, der eine immunantwort gegen ein glykosphingolipid induziert und seine verwendung
FI941572A7 (fi) Anti-erbB-2-monoklonaalisten vasta-aineiden yhdistelmä ja käyttömenete lmä
DE69109954D1 (de) Selbsthebender und nichtausladender Lehnstuhl.
FI925631A7 (fi) Monoklonaaliset vasta-aineet
BR9106392A (pt) Anticorpos anti-icam-1 enxertados-cdr humanizados,metodos de preparacao e uso dos mesmos
DE69530415D1 (de) Rekombinierte sequenzen des monoklonalen anti-idiotypischen antikörpers 3h1, diean dem menschlichen karzioembyonischen antigen liiert sind
IT8020166A0 (it) Procedimento e dispositivo per fissare pastiglie d'usura ad attrito.
DE69010669D1 (de) Reibbelag und belagträgerscheibe.
ITMI910754A0 (it) Procedimento e disposizione per condensare sostanze vaporose
DE3788148D1 (de) Monoklonale Antikörper und deren Verwendung.
IT1207589B (it) Composizione di anticorpi monoclonali umani cross-protettivi.
NO910209D0 (no) Fremgangsmaate for fremstilling av rekombinante humane anti-cd18 antistoffer.
ITRM910842A1 (it) Collaudo elettromagnetico di funi metalliche.
IT8249377A0 (it) Fermaglio perfezionato per articolidi gioielleria e simili
DE3689948D1 (de) Monoklonale antikörper und testverfahren.
DE69014132D1 (de) Reibbeläge und trägereinheit.
DK0409495T3 (da) Sammensætninger til friktionselementer
DE3888604D1 (de) Monoklonale Antikörper gegen Antithrombinbindende Substanz und seine Verwendungen.
FI943524A0 (fi) Hepatiitti C -viruksen vastaisia monoklonaalisia vasta-aineita ja anti-idiotyyppisiä vasta-aineita
MX9202642A (es) Anticuerpos monoclonales y antigeno para melanoma humano.
IT215689Z2 (it) Dispositivo di fissaggio di elementi sensori come termostati e simili.
NO912509D0 (no) Fremgangsmaate for fremstilling av substituerte acykliske nukleosider og mellomprodukter derav.
DE3650327D1 (de) Monoklonaler Antikörper gegen die polymorphe Determinante B27 des HLA.
DE59003265D1 (de) Verwendung von nor-verapamil und nor-gallopamil als antiarteriosklerotica.
DE3787416D1 (de) Monoklonaler Antikörper gegen Laforakörper.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee